Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cavosonstat + Ivacaftor in CF (F508del/Gating)
NCT02724527Phase 2Unknown
- Sponsor
- Nivalis Therapeutics
- Start
- Apr 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cavosonstat in cystic fibrosis (CF), sponsored by Nivalis Therapeutics. Status: unknown.
02
Drugs
cavosonstat
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02724527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02724527.